MyRealWorld MG study announcement

MyRealWorld MG study announcement

The MyRealWorld MG study, a longitudinal digital observational study exploring the impact of myasthenia gravis (MG) from the patient perspective, has been run by Vitaccess on behalf of argenx since December 2019. Since then, over 2,400 adults with MG residing across...
American Health Research study launch

American Health Research study launch

We are delighted to announce that this month, American Health Research, in collaboration with Vitaccess, have launched the investigator-initiated AHR CB study. The study is designed to help researchers learn how Mucinex® could be used as a long-term treatment to...
Delphi panels and the case for consensus

Delphi panels and the case for consensus

In the hierarchy of evidence, randomized controlled trials are the gold standard. While seeking expert opinion will never compare in terms of scientific rigor, it can be a valuable option in cases of limited, insufficient, or conflicting information. This is, of...
Join our ISPOR short course

Join our ISPOR short course

Join Dr Mark Larkin, Dr Catherine Bottomley, and Dr Casey Quinn for the virtual ISPOR short course on Digital Real-World Evidence Generation Approaches in Rare Diseases and Oncology. The course is designed to provide a good understanding of how to plan and undertake...
Skip to content